Published in Hepatitis Weekly, May 14th, 2007
The India Pharmaceuticals & Healthcare Report provides independent forecasts and competitive intelligence on India's pharmaceuticals & healthcare industry.
India continues to hold a significant pharmaceutical market potential, not least due to its large and rapidly expanding population. Prescription drugs account for around two-thirds of the total market, with over-the-counter (OTC) products likely to benefit from the liberalisation of retail channels anticipated during the forecast...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.